Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Dr. Anaїs Rameau, an assistant professor of otolaryngology and an attending laryngologist at the Sean Parker Institute for the Voice at Weill Cornell Medicine, has been awarded a Paul B. Beeson Emerging Leaders Career Development Award in Aging by the National Institute on Aging, the American Federation for Aging Research and the John A. Hartford Foundation.

26 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

First patient version of the ESC Guidelines on cardiovascular disease prevention unveiled today

The first patient version of the European Society of Cardiology Guidelines on cardiovascular disease prevention are unveiled today at ESC Congress 2022.

26 Aug 2022

Suboptimal sleep linked with higher risk of heart disease and stroke

Nine in ten people do not get a good night's sleep, according to research presented at ESC Congress 2022.

26 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Research reveals specific brain area responsible for effortful altruistic behavior

An area of the brain specifically involved in putting in effort to help others out has been pinpointed by scientists at the University of Birmingham and University of Oxford.

26 Aug 2022

COVID-19 vaccine not linked to increased risk of stroke

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does.

24 Aug 2022

Study investigates associations between MS prevalence and factors driving regional differences

Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure.

24 Aug 2022

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Targeting Na+/K+ ATPase alpha 1 (ATP1A1) subunit proteins could help identify novel therapies for addressing blood clots and thrombosis, according to a new study by Marshall University researchers.

24 Aug 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

New wireless sock monitoring system reduces fall rates among hospitalized patients

Research led by nurses at The Ohio State University Wexner Medical Center found that a new wireless sock monitoring system reduced fall rates among "fall-risk" patients hospitalized at Ohio State's Brain and Spine Hospital.

23 Aug 2022

Surprising culprit contributes significantly to the brain destruction after stroke or TBI

In the aftermath of a stroke or TBI, a group of amino acids that typically support brain function contribute significantly to the brain destruction that can follow both these injuries, scientists report.

23 Aug 2022

Study shows urban-rural differences in hypertension prevalence in low-income and middle-income countries

A meta-analysis comparing differences in the prevalence of hypertension between urban and rural areas in low- and middle-income countries (LMICs) concludes that the prevalence of hypertension increased between 1990 and 2020 in both urban and rural areas, but with a more pronounced trend in rural areas.

22 Aug 2022

Mandatory fortification of flour with folic acid has potential to prevent neural tube defects

The UK Government's current proposal to fortify one type of flour with folic acid is inadequate as it suggests a low dose that would fail to prevent hundreds of cases of severe birth defects each year, according to a new paper by UCL's Professor Sir Nicholas Wald.

22 Aug 2022

Discovery of a group of latent stem cells could offer a new approach to treat brain and spinal cord injuries

Scientists at the Francis Crick Institute have identified a group of latent stem cells that respond to injury in the central nervous system of mice. If a similar type of cell exists in humans, they could offer a new therapeutic approach to treat brain and spinal cord injuries.

22 Aug 2022

Stroke News and Research

Further Reading

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Study compares the benefits of taking antihypertensive medication in the morning or evening

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

First patient version of the ESC Guidelines on cardiovascular disease prevention unveiled today

Suboptimal sleep linked with higher risk of heart disease and stroke

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Research reveals specific brain area responsible for effortful altruistic behavior

COVID-19 vaccine not linked to increased risk of stroke

Study investigates associations between MS prevalence and factors driving regional differences

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

New wireless sock monitoring system reduces fall rates among hospitalized patients

Surprising culprit contributes significantly to the brain destruction after stroke or TBI

Study shows urban-rural differences in hypertension prevalence in low-income and middle-income countries

Mandatory fortification of flour with folic acid has potential to prevent neural tube defects

Discovery of a group of latent stem cells could offer a new approach to treat brain and spinal cord injuries

Intake of lysine prevents hypertensive kidney disease in animal models

What is the association between COVID-19 and thrombotic events?

Key gene sheds light on how people develop tolerance to pain-relievers over time

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News